Nirmal K. Chaudhary, John I. Pitt, Ernest Lacey, Andrew Crombie, Daniel Vuong, Andrew M. Piggott, and Peter Karuso
J. Nat. Prod., 2018, 81, 1517–1526
Publication Date: June 19, 2018
https://doi.org/10.1021/acs.jnatprod.7b00816
Abstract:
Chemical investigation of an Australian fungus, Aspergillus banksianus, led to the isolation of the major metabolite banksialactone A (1), eight new isochromanones, banksialactones B–I (2–9), two new isocoumarins, banksiamarins A and B (10 and 11), and the reported compounds, clearanol I (12), dothideomynone A (13), questin (14), and endocrocin (15). The structures of 1–11 were established by NMR spectroscopic data analysis, and the absolute configurations were determined from optical rotations and ECD spectra in conjunction with TD-DFT calculations. The secondary metabolite profile of A. banksianus is unusual, with the 11 most abundant metabolites belonging to a single isochromanone class. Conjugation of 1 with endocrocin, 5-methylorsellinic acid, 3,5-dimethylorsellinic acid, mercaptolactic acid, and an unknown methylthio source gave rise to five unprecedented biosynthetic hybrids, 5–9. The isolated compounds were tested for cytotoxicity, antibacterial, and antifungal activities, with hybrid metabolites 7–9 displaying weak cytotoxic and antibiotic activities.
Available at BioAustralis: